Stoke Therapeutics, Inc. (STOK) Operating margin 2022–2025
Stoke Therapeutics, Inc. (STOK) operating margin by fiscal year — reported operating income divided by reported revenue.
-11.2%FY2025 · since FY2022: -841.2% → -11.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.2% | +266.1 pp |
| FY2024 | -277.3% | +1029.9 pp |
| FY2023 | -1307.2% | -466.0 pp |
| FY2022 | -841.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice